EXECUTIVE CLINICAL SERVICES LIMITEDActive

Company number 04580763Private limited companyIncorporated 2002

Key figures

£312,998+33.9%
Net assets 2023/24
+31.9%
Average annual growth 2019/20–2023/24
0100 k200 k300 k400 k2019/202020/212021/222022/232023/24

Like most small UK companies, EXECUTIVE CLINICAL SERVICES LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2023/24
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2019/202020/212021/222022/232023/24
Filed accounts2019/20–2023/24
2019/202020/212021/222022/232023/24
Cash at bank and in hand115,11955,01227,35299,58443,983
Total assets134,957185,830234,722317,704429,853
Total liabilities———84,276116,857
Net assets / total equity103,440154,806183,154233,703312,998
Average number of employees22220

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: EXECUTIVE CLINICAL SERVICES LIMITED

Company

EXECUTIVE CLINICAL SERVICES LIMITED is a private limited company registered with Companies House under company number 04580763. It was incorporated on 4 Nov 2002. Its status is active. The registered office is in Droitwich (WR9). Its nature of business (SIC 2007) is general medical practice activities (86210).

Accounts

The latest accounts in the database are for 2023/24 (period ending 29 Nov 2024); the company files small company accounts (filleted). Net assets were £312,998, up 33.9% on the previous year. Cash at bank and in hand was £43,983. Total assets were £429,853 and total liabilities £116,857. The company had an average of 0 employees. Figures are available for 5 financial years (2019/20–2023/24).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 24 Nov 2026. The next confirmation statement is due by 17 Nov 2026.